VJNeurology is committed to improving our service to you

Share this video  

VJNeurology is committed to improving our service to you

EAN 2020 | Perspectives on the early recognition of advanced Parkinson’s disease

Per Odin • 27 May 2020
EAN 2020
Movement Disorders Parkinson's Disease Apomorphine Levodopa
EARLYSTIM Diagnostics Surgery Treatment Trial Updates

Per Odin, MD, PhD, Lund University, Lund, Sweden, outlines the importance of early and accurate recognition of advanced Parkinson’s disease. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from Per Odin

2:18
Are patients with advanced Parkinson's disease identified early enough?
Per Odin • 27 May 2020
1:39
Quality of life in patients with late-stage Parkinson’s disease
Per Odin • 17 Sep 2022
1:14
Continuous dopaminergic stimulation: Advanced treatments in Parkinson’s disease
Per Odin • 17 Sep 2022
0:56
Barriers to effective symptom management in Parkinson’s disease
Per Odin • 17 Sep 2022

Related Videos

5:22
Regenerative medicine-based approaches in Parkinson’s disease
Alfonso Fasano • 19 Oct 2023
7:21
Recent developments in cell replacement therapy for Parkinson’s disease
Alfonso Fasano • 19 Oct 2023
1:12
Functional electrical stimulation: beyond stroke
Rosalyn Grabarz • 12 Oct 2023
2:08
The future of neuromodulation in movement disorders
Alfonso Fasano • 7 Sep 2023
The content of VJNeurology is intended for healthcare professionals